Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders

Background: N6-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. But its role in neuromyelitis optica spectrum disorders (NMOSD) is not known.Aims: To explore the mechanism of m6A in NMOSD patients.Methods: This study assessed the m6...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hong Yang, Yi-Fan Wu, Jie Ding, Wei Liu, De-Sheng Zhu, Xia-Feng Shen, Yang-Tai Guan
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/e878a203c000404e831165b23d4609b3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e878a203c000404e831165b23d4609b3
record_format dspace
spelling oai:doaj.org-article:e878a203c000404e831165b23d4609b32021-11-11T07:43:34ZComprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders1664-802110.3389/fgene.2021.735454https://doaj.org/article/e878a203c000404e831165b23d4609b32021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fgene.2021.735454/fullhttps://doaj.org/toc/1664-8021Background: N6-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. But its role in neuromyelitis optica spectrum disorders (NMOSD) is not known.Aims: To explore the mechanism of m6A in NMOSD patients.Methods: This study assessed the m6A methylation levels in blood from two groups: NMOSD patients and healthy controls. Methylated RNA immunoprecipitation Sequencing (MeRIP-seq) and RNA-seq were performed to assess differences in m6A methylation between NMOSD patients and healthy controls. Ultra-high performance liquid chromatography coupled with triple quadruple mass spectrometry (UPLC-QQQ-MS) method was performed to check m6A level. Differential m6A methylation genes were validated by MeRIP-qPCR.Results: Compared with that in the control group, the total m6A level was decreased in the NMOSD group. Genes with upregulated methylation were primarily enriched in processes associated with RNA splicing, mRNA processing, and innate immune response, while genes with downregulated methylation were enriched in processes associated with the regulation of transcription, DNA-templating, and the positive regulation of I-kappa B kinase/NF-kappa B signalling.Conclusion: These findings demonstrate that differential m6A methylation may act on functional genes to regulate immune homeostasis in NMOSD.Hong YangYi-Fan WuJie DingWei LiuDe-Sheng ZhuXia-Feng ShenYang-Tai GuanYang-Tai GuanFrontiers Media S.A.articleneuromyelitis optica spectrum disorderimmune homeostasisN6-methyladenosine (m6A) methylationdifferential methylation peaksMeRIP-seqUPLC-QQQ-MSGeneticsQH426-470ENFrontiers in Genetics, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic neuromyelitis optica spectrum disorder
immune homeostasis
N6-methyladenosine (m6A) methylation
differential methylation peaks
MeRIP-seq
UPLC-QQQ-MS
Genetics
QH426-470
spellingShingle neuromyelitis optica spectrum disorder
immune homeostasis
N6-methyladenosine (m6A) methylation
differential methylation peaks
MeRIP-seq
UPLC-QQQ-MS
Genetics
QH426-470
Hong Yang
Yi-Fan Wu
Jie Ding
Wei Liu
De-Sheng Zhu
Xia-Feng Shen
Yang-Tai Guan
Yang-Tai Guan
Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders
description Background: N6-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. But its role in neuromyelitis optica spectrum disorders (NMOSD) is not known.Aims: To explore the mechanism of m6A in NMOSD patients.Methods: This study assessed the m6A methylation levels in blood from two groups: NMOSD patients and healthy controls. Methylated RNA immunoprecipitation Sequencing (MeRIP-seq) and RNA-seq were performed to assess differences in m6A methylation between NMOSD patients and healthy controls. Ultra-high performance liquid chromatography coupled with triple quadruple mass spectrometry (UPLC-QQQ-MS) method was performed to check m6A level. Differential m6A methylation genes were validated by MeRIP-qPCR.Results: Compared with that in the control group, the total m6A level was decreased in the NMOSD group. Genes with upregulated methylation were primarily enriched in processes associated with RNA splicing, mRNA processing, and innate immune response, while genes with downregulated methylation were enriched in processes associated with the regulation of transcription, DNA-templating, and the positive regulation of I-kappa B kinase/NF-kappa B signalling.Conclusion: These findings demonstrate that differential m6A methylation may act on functional genes to regulate immune homeostasis in NMOSD.
format article
author Hong Yang
Yi-Fan Wu
Jie Ding
Wei Liu
De-Sheng Zhu
Xia-Feng Shen
Yang-Tai Guan
Yang-Tai Guan
author_facet Hong Yang
Yi-Fan Wu
Jie Ding
Wei Liu
De-Sheng Zhu
Xia-Feng Shen
Yang-Tai Guan
Yang-Tai Guan
author_sort Hong Yang
title Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders
title_short Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders
title_full Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders
title_fullStr Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders
title_full_unstemmed Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders
title_sort comprehensive analysis of n6-methyladenosine (m6a) methylation in neuromyelitis optica spectrum disorders
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/e878a203c000404e831165b23d4609b3
work_keys_str_mv AT hongyang comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders
AT yifanwu comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders
AT jieding comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders
AT weiliu comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders
AT deshengzhu comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders
AT xiafengshen comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders
AT yangtaiguan comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders
AT yangtaiguan comprehensiveanalysisofn6methyladenosinem6amethylationinneuromyelitisopticaspectrumdisorders
_version_ 1718439452312862720